SPINEMarketGroup

Salt Lake City, UT — October 23, 2025 — DiscGenics, Inc., a privately held, late-stage clinical biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the publication of pioneering research demonstrating the first … [Read More...] about DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research

At Additive Surgical, we’ve reimagined what a spinal implant can be. After more than four years of intensive research and development, we are proud to introduce PorOssity™, our flagship range of spine implants that redefines the relationship between technology, biology, and clinical performance. A New Era in Spinal Implant Design PorOssity™ embodies a major leap forward in implant … [Read More...] about Introducing PorOssity™: Additive Surgical’s Flagship Range of Spine Implants

WEST CHESTER, Pa., Oct. 28, 2025 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of over $32 million in worldwide revenue … [Read More...] about Centinel Spine® Grows prodisc® Total Disc Replacement 42% Worldwide in Third Quarter 2025 with Record EBITDA Results

An idea born from bridge safety monitoring may soon transform medicine. At the University of Pittsburgh, a team of civil engineers and neurosurgeons is developing the first self-powered spinal implant capable of sending real-time data from inside the body. Professors Amir Alavi, Nitin Agarwal, and D. Kojo Hamilton recently received a $352,000 grant from the National Institutes of Health (NIH) … [Read More...] about What If a Bridge Could Inspire the Next Breakthrough in Spinal Implants?

CARLSBAD, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the launch of Aurora Biologics, a new division dedicated to advancing spinal fusion success through best-in-class biologic innovation. The establishment of Aurora Biologics … [Read More...] about Aurora Spine Launches New Biologics Portfolio

Some thoughts on distributors and their current role.... Markets evolve over time, and the spinal implant industry is no exception. Over the past three decades, it has transformed from being dominated by a few companies—such as Sofamor Danek, Acromed, Synthes, and Aesculap—offering a limited range of products, to a highly diversified and competitive field. What once consisted mainly of plates … [Read More...] about Beyond Sales: How Can Distributors Redefine Their Value in Spine Care? Do They Still Have a Future?

Back in the early 2000s, lumbar artificial disc replacements were introduced as a fresh alternative for people dealing with degenerative spine problems. Instead of locking the vertebrae together through fusion, these implants aimed to keep the spine moving naturally, reduce strain on nearby segments, and help patients get back to normal life.Over time, though, the initial excitement faded as the … [Read More...] about Why Lumbar Artificial Disc Replacements Are Poised to Make a Comeback?

BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new Category I CPT® code, 63032, for bone-anchored annular closure, effective January 1, 2026. This new add-on CPT code specifically describes the adjunctive placement of a … [Read More...] about Intrinsic Therapeutics Announces that AMA Released CPT 2026 Code Set Including New CPT Code 63032 Describing Bone-Anchored Annular Closure, Effective January 1, 2026

This week, we’ve reported several developments related to cervical disc prostheses. Yesterday, we covered the launch and presentation of a new cervical disc prosthesis by a French company at the EuroSpine congress. We also reported on a new distribution agreement for disc prostheses in Australia. In addition, Centinel Spine® received two-level FDA approval for its prodisc® C Vivo and prodisc® C SK … [Read More...] about (UPDATED 2025): Cervical Disc Prostheses – Global Status & Trends.Which Ones Survived, Who’s Leading, and What Are the Real Options in 2025?

Copenhagen, October 2025 – At EUROSPINE 2025, Cousin Surgery proudly announces the launch of its latest innovation in spinal surgery: the new Cervical Disc Prosthesis, a key addition to its comprehensive Motion Preservation portfolio. Designed to achieve controlled mobility, autostability, and self-centering, the new disc prosthesis offers an optimal balance between motion preservation and … [Read More...] about Cousin Surgery Unveils New Cervical Disc Prosthesis at EUROSPINE 2025

Sydney, Australia – 22 October 2025 – Evolution Surgical is pleased to announce a tri-party agreement with Spineway, the manufacturer of the CP-ESP and LP-ESP disc replacement products, and Orthotech, the previous distributor, to take over exclusive distribution in Australia from 25 October 2025. The CP-ESP and LP-ESP viscoelastic disc prostheses are among the most trusted and widely implanted … [Read More...] about Evolution Surgical to Distribute CP-ESP and LP-ESP Disc Replacement Products in Australia from 25 October 2025

For the first time in history, a company has successfully 3D printed a 5.5 mm diameter pedicle screw capable of withstanding the rigorous testing required for FDA clearance — a goal that many have pursued for decades without success.This milestone represents not just a regulatory achievement, but a breakthrough in the convergence of advanced engineering and biological science. Why Is Spinal … [Read More...] about Can 3D Printing Prevent Pedicle Screw Loosening—Is This the Breakthrough Spine Surgery Has Been Waiting For?

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today announces the signing of a … [Read More...] about SMAIO Signs a New Distribution Agreement for Its Open Platform KEOPS-4ME With Orthofix in the U.S.